EVALUATION AGREEMENTEvaluation Agreement • November 9th, 2004 • Aclara Biosciences Inc • Measuring & controlling devices, nec • Delaware
This EVALUATION AGREEMENT (together with all exhibits attached hereto, the “Agreement”), effective September 22, 2004 (“Effective Date”), is by and between SmithKline Beecham Corporation, doing business as GlaxoSmithKline, a Pennsylvania corporation with a place of business at One Franklin Plaza, Philadelphia, Pennsylvania 19101 (“GSK”) and ACLARA BioSciences, Inc., a Delaware corporation with offices at 1288 Pear Avenue, Mountain View, California 94043 (“ACLARA”).
